0001437749-24-003012.txt : 20240202 0001437749-24-003012.hdr.sgml : 20240202 20240202190422 ACCESSION NUMBER: 0001437749-24-003012 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20240131 FILED AS OF DATE: 20240202 DATE AS OF CHANGE: 20240202 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Barrett Elizabeth A. CENTRAL INDEX KEY: 0001764157 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38079 FILM NUMBER: 24593449 MAIL ADDRESS: STREET 1: C/O UROGEN PHARMA LTD. STREET 2: 9 HA'TA'ASIYA STREET CITY: RA'ANANA STATE: L3 ZIP: 4365007 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: UroGen Pharma Ltd. CENTRAL INDEX KEY: 0001668243 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 000000000 STATE OF INCORPORATION: L3 FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 9 HA'TA'ASIYA ST CITY: RA'ANANA STATE: L3 ZIP: 4365007 BUSINESS PHONE: 972 9 770 7601 MAIL ADDRESS: STREET 1: 9 HA'TA'ASIYA ST CITY: RA'ANANA STATE: L3 ZIP: 4365007 4 1 rdgdoc.xml FORM 4 X0508 4 2024-01-31 0001668243 UroGen Pharma Ltd. URGN 0001764157 Barrett Elizabeth A. 400 ALEXANDER PARK DRIVE PRINCETON NJ 08540 1 Chief Executive Officer 0 Restricted Stock Units 2024-01-31 4 A 0 87615 0 A Ordinary Shares 87615 87615 D Each restricted stock unit ("RSU") represents a contingent right to receive one ordinary share of the Issuer. 1/3 of the shares underlying the restricted stock units will vest on each of January 31, 2025, January 31, 2026 and January 31, 2027. /s/ Jason D. Smith, Attorney-in-Fact 2024-02-02